Article
Specialty Care and Counselling about Hereditary Cancer Risk Improves Adherence to Cancer Screening and Prevention in Newfoundland and Labrador Patients with BRCA1/2 Pathogenic Variants: A Population-Based Retrospective Cohort Study.
Current oncology (Toronto, Ont.) - 22 Oct 2023
Roebothan Aimee, Smith Kerri N, Seal Melanie, Etchegary Holly, Dawson Lesa
Abstract excerpt
Pathogenic variants (PVs) in BRCA1 and BRCA2 increase the lifetime risks of breast and ovarian cancer. Guidelines recommend breast screening (magnetic resonance imaging (MRI) and mammogram) or risk-reducing mastectomy (RRM) and salpingo-oophorectomy (RRSO). We sought to (1) characterize the population of BRCA1/2 PV carriers in Newfoundland and Labrador (NL), (2) evaluate risk-reducing interventions, and (3)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.